An open-label, randomized, parallel-group, adaptive design with
blinded outcome adjudication trial conducted to compare the
efficacy and safety of milvexian and enoxaparin in patients
undergoing elective knee arthroplasty.
About the Podcast
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.